Latest News & Updates

Breaking News

  • 3 hours ago

  • Pharma Now Editorial Team

Leinco-CellCarta Alliance Targets Biomarker Discovery Gap
Breaking News
KEYTRUDA Bladder Cancer Combo Wins FDA Priority Review

Pharma Now Editorial Team

Other trending news you may like to read

Leinco-CellCarta Alliance Targets Biomarker Discovery Gap

Leinco and CellCarta partner to integrate proteomics tools for biomarker discovery in oncology and targeted therapy development.

Pharma Now Editorial Team

Pharma Now

KEYTRUDA Bladder Cancer Combo Wins FDA Priority Review

Merck secures FDA priority review for KEYTRUDA and KEYTRUDA QLEX plus Padcev in bladder cancer, accelerating manufacturing and supply chain decisions.

Pharma Now Editorial Team

Pharma Now

Asahi Kasei Closes Aicuris Deal in Infectious Disease Bet

Asahi Kasei completes Aicuris acquisition, targeting severe infectious diseases and a global specialty pharma platform.

Pharma Now Editorial Team

Pharma Now

EU Grants Conditional Approval for First Targeted pLGG Therapy

Ipsen's tovorafenib becomes the EU's first targeted therapy for relapsed or refractory pediatric low-grade glioma, backed by Phase II FIREFLY-1 data.

Pharma Now Editorial Team

Pharma Now